habener glp-1 Harvard Medical School Researcher Wins 2025 Breakthrough Prize for Work on Lasker Award Winner: GLP-1 Drugs

Retatrutide is an investigational weekly injection targeting three hormone receptors (GLP1, GIP and glucagon) to support weight loss

Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain

Third-Party Testing Independent, third-party lab verification removes the conflict of interest that comes with in-house testing

The National Center for Complementary and Integrative Health (NCCIH) acknowledges that certain botanicals studied for glucose management - including berberine, cinnamon extract, and chromium - have published evidence behind them, while consistently noting that evidence quality varies and that most studies involve oral, not transdermal, administration